Simulations of site-specific target-mediated pharmacokinetic models for guiding the development of bispecific antibodies (Q86455105)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

Simulations of site-specific target-mediated pharmacokinetic models for guiding the development of bispecific antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

Vaishali L Chudasama

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Anup Zutshi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Pratap Singh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Anson K Abraham

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Donald E Mager

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

John M Harrold

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

6 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmacokinetics and Pharmacodynamics

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

1-18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25559227%20AND%20SRC:MED&resulttype=core&format=json

Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency.

26 February 2020

cites work

1 reference

12 December 2020

The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway

1 reference

12 December 2020

Antibody pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human

1 reference

12 December 2020

Inflammatory bowel disease: cause and immunobiology

1 reference

12 December 2020

Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human

1 reference

12 December 2020

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma

1 reference

12 December 2020

Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130

1 reference

12 December 2020

Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.

1 reference

12 December 2020

General pharmacokinetic model for drugs exhibiting target-mediated drug disposition

1 reference

12 December 2020

Biodistribution of [125I]-labeled therapeutic proteins: application in protein drug development beyond oncology

1 reference

12 December 2020

Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice

1 reference

12 December 2020

Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deployment.

1 reference

12 December 2020

B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).

1 reference

12 December 2020

Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease

1 reference

12 December 2020

Treatment of allergic asthma: modulation of Th2 cells and their responses

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development

1 reference

12 December 2020

Differences in expression, affinity, and function of soluble (s)IL-4Ralpha and sIL-13Ralpha2 suggest opposite effects on allergic responses

1 reference

12 December 2020

Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site

1 reference

12 December 2020

Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus

1 reference

12 December 2020

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

1 reference

12 December 2020

Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer

1 reference

12 December 2020

Buy buy bispecific antibodies.

1 reference

12 December 2020

Disappearance kinetics of solutes from synovial fluid after intra-articular injection

1 reference

12 December 2020

Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.

1 reference

12 December 2020

Mapping the domain(s) critical for the binding of human tumor necrosis factor-alpha to its two receptors

1 reference

12 December 2020

The affinity of human RANK binding to its ligand RANKL.

1 reference

12 December 2020

Bispecific T-cell engaging antibodies for cancer therapy

1 reference

12 December 2020

Inducible costimulator-positive T cells are required for allergen-induced local B-cell infiltration and antigen-specific IgE production in lung tissue.

1 reference

12 December 2020

Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.

1 reference

12 December 2020

Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis.

1 reference

12 December 2020

Issues, challenges, and opportunities in model-based drug development for monoclonal antibodies

1 reference

12 December 2020

The B7 family revisited

1 reference

12 December 2020

Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin

1 reference

12 December 2020

Smarter drugs: a focus on pan-specific monoclonal antibodies

1 reference

12 December 2020

Target-mediated drug disposition model for drugs that bind to more than one target

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of monoclonal antibodies--mechanistic modeling applied to drug development.

1 reference

12 December 2020

Airway wall expression of OX40/OX40L and interleukin-4 in asthma

1 reference

12 December 2020

A chemokine-driven positive feedback loop organizes lymphoid follicles

1 reference

12 December 2020

Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

1 reference

12 December 2020

Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice

1 reference

12 December 2020

Model-based drug development

1 reference

12 December 2020

Follicular stromal cells and lymphocyte homing to follicles.

1 reference

12 December 2020

Untangling the complex web of IL-4- and IL-13-mediated signaling pathways

1 reference

12 December 2020

Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma

1 reference

12 December 2020

Defining dose-response relationships in the therapeutic blockade of B7RP-1-dependent immune responses

1 reference

12 December 2020

Local versus systemic anti-tumour necrosis factor-α effects of adalimumab in rheumatoid arthritis: pharmacokinetic modelling analysis of interaction between a soluble target and a drug

1 reference

12 December 2020

Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody

1 reference

12 December 2020

Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity

1 reference

12 December 2020

Interleukin-4 (B-cell stimulatory factor-1) augments the in vivo generation of cytotoxic cells in immunosuppressed animals

1 reference

12 December 2020

Monoclonal antibody pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies

1 reference

12 December 2020

The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor

1 reference

12 December 2020